4D MOLECULAR THERAPEUTICS IN (FDMT) Stock Income Statement
USA - NASDAQ:FDMT - US35104E1001 - Common Stock
10.99 USD
+0.19 (+1.76%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.00K | 37.00K | 20.72M | 3.13M | 18.04M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 220.36M | 187.88M | 133.59M | 113.16M | 89.37M | |||
| Research and Development | 170.22M | 141.30M | 97.10M | 80.25M | 61.36M | |||
| Selling, General, and Administrative Expenses | 50.14M | 46.58M | 36.49M | 32.91M | 28.01M | |||
| Operating Income | -220.33M | -187.84M | -112.87M | -110.03M | -71.33M | |||
| Interest Income/Expense | 24.20M | 27.05M | 12.21M | 2.57M | 140.00K | |||
| Other Income/Expense | -16.00K | -77.00K | -181.00K | -40.00K | -120.00K | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -196.14M | -160.87M | -100.84M | -107.49M | -71.32M | |||
| Income Tax | null | 0 | null | null | null | |||
| Net Income | -196.14M | -160.87M | -100.84M | -107.49M | -71.32M | |||
| EBITDA | -215.82M | -183.19M | -108.66M | -107.63M | -69.81M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.5198 | -2.9821 | -2.577 | -3.32 | -2.57 | |||
| Non GAAP EPS | -3.53 | -2.98 | -2.64 | -3.32 | -2.56 | |||
| Statistics | ||||||||
| Profit Margin | -594375.76% | -434778.38% | -486.59% | -3434.19% | -395.34% | |||
| Operating Profit Margin | -667654.55% | -507678.38% | -544.65% | -3515.34% | -395.40% | |||
All data in USD